MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-19-0079544
RDW Pharmaceuticals Private Limited
RDW Pharmaceuticals Private Limited - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2024
₹47.05 Lakh
▲ 15% YoY
Net profit · FY 2024
₹3.1 Lakh
Net margin 6.6%
EBITDA · FY 2024
₹4.26 Lakh
EBITDA margin 9.1%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
7
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About RDW Pharmaceuticals Private Limited
Data last updated:
RDW Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 25 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2021PTC362747.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohd Shakil Abdul Khalil and Yogesh Baburao Teple.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hedf B – 31 – 3 – 12 Dawri Nagar Gate No. 1 Service Road Santacruz East, Mumbai, Maharashtra, India – 400055.
As per the financials filed for FY 2024, the company reported a revenue of ₹47.05 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹3.1 Lakh (net margin 6.6%) and EBITDA of ₹4.26 Lakh (EBITDA margin 9.1%).
RDW Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0079544).
Company details
CIN U24110MH2021PTC362747
Registration Number 362747
Incorporation Date 25 June 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0079544
Key People
Mohd Shakil Abdul Khalil Director Yogesh Baburao Teple Director Farkhanda Azhar Hussain Director Recognitions & Rankings of RDW Pharmaceuticals
Contact details
RDW Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressHedf B – 31 – 3 – 12 Dawri Nagar Gate No. 1 Service Road Santacruz East, Mumbai, Maharashtra, India – 400055
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
Comprehensive company report
RDW Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of RDW Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of RDW Pharmaceuticals Private Limited, buy the company report.
Financials of RDW Pharmaceuticals Private Limited
FY 2025 filings availableRDW Pharmaceuticals Private Limited reported revenue of ₹47.05 Lakh (up 15% YoY) for FY 2024.
Revenue · FY 2024
₹47.05 Lakh ▲ 15%
Net profit · FY 2024
₹3.1 Lakh margin 6.6%
EBITDA · FY 2024
₹4.26 Lakh margin 9.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
EBITDA CAGR growth
1 year
▲ 146%
Revenue rose 15% in the latest year. EBITDA rose 146% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹4.26 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹3.1 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 9.1% | ||
| Net Profit Margin | 6.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of RDW Pharmaceuticals Private Limited, buy the company report.
Board of directors of RDW Pharmaceuticals Private Limited
RDW Pharmaceuticals has 7 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Shakil Abdul Khalil Also directs: Romoz Constructions LLP | Director | 25 Jun 2021 | 5 Years 4 Months | Current |
| Yogesh Baburao Teple Also directs: Lifetime Pipes Private Limited | Director | 18 Aug 2021 | 5 Years 2 Months | Current |
| Farkhanda Azhar Hussain Also directs: Afza Healthcare LLP | Director | 18 Aug 2021 | 5 Years 2 Months | Current |
| Aruna Budhagiri Shankaracharya | Director | 10 May 2022 | 4 Years 5 Months | Current |
| Chetan Jugalkishor Darak | Director | 10 May 2022 | 4 Years 5 Months | Current |
| Monali Narendra Fiske Also directs: PN Advanced Manufacturing Private Limited | Director | 10 May 2022 | 4 Years 5 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
RDW Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KHK Pharmaceuticals Private Limited | ₹47.22 Lakh (FY 2023) | 183.0% | New Delhi, Delhi, India | |||
| Inverse Pharmaceuticals Private Limited | ₹47.09 Lakh (FY 2023) | 42.0% | Kanpur, Uttar Pradesh, India | |||
| RDW Pharmaceuticals Private Limitedthis company | ₹47.05 Lakh (FY 2024) | ₹3.1 Lakh | 6.6% | 15.0% | Mumbai, Maharashtra, India | |
| Alkyd Pharmaceuticals Private Limited | ₹47.01 Lakh (FY 2023) | -32.0% | Dhanbad, Jharkhand, India | |||
| Ocuris Pharmaceuticals Private Limited | ₹46.98 Lakh (FY 2021) | 12.0% | Gurgaon, Haryana, India |
To see the full peer comparison of RDW Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving RDW Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for RDW Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for RDW Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
RDW Pharmaceuticals Private Limited has 8 board changes on record since 2021: 7 appointments and 1 cessation. The latest: Aruna Budhagiri Shankaracharya was appointed as Director on 10 May 2022.
AGM
Rdw Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rdw Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Aruna Budhagiri Shankaracharya was appointed as Director.
Appointed
Chetan Jugalkishor Darak was appointed as Director.
Appointed
Kunda Vasudev Jawale was appointed as Director.
Appointed
Monali Narendra Fiske was appointed as Director.
Ceased
Maviya Fauzan Khan Sohail Ahmad Khan ceased to be Director.
Appointed
Farkhanda Azhar Hussain was appointed as Director.
Appointed
Yogesh Baburao Teple was appointed as Director.
Appointed
Mohd Shakil Abdul Khalil was appointed as Director.
Incorporation
25 Jun 2021
Rdw Pharmaceuticals Private Limited was registered on 25 Jun 2021 with Roc Mumbai & aged 5 years 4 months as per MCA records.
Frequently asked questions
RDW Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 25 June 2021 (5+ years old) and is registered under CIN U24110MH2021PTC362747.
RDW Pharmaceuticals has 7 current directors:
- Mohd Shakil Abdul Khalil - Director
- Yogesh Baburao Teple - Director
- Farkhanda Azhar Hussain - Director
- Aruna Budhagiri Shankaracharya - Director
- Chetan Jugalkishor Darak - Director
- Monali Narendra Fiske - Director
- Kunda Vasudev Jawale - Director
The latest financial statements of RDW Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of RDW Pharmaceuticals is U24110MH2021PTC362747. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
RDW Pharmaceuticals was incorporated on 25 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of RDW Pharmaceuticals by revenue are KHK Pharmaceuticals Private Limited, Inverse Pharmaceuticals Private Limited, Alkyd Pharmaceuticals Private Limited, Ocuris Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Aruna Budhagiri Shankaracharya was appointed as Director on 10 May 2022. Chetan Jugalkishor Darak was appointed as Director on 10 May 2022. Kunda Vasudev Jawale was appointed as Director on 10 May 2022. RDW Pharmaceuticals has 8 board changes on record in total.
Yes, RDW Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0079544).
The registered office of RDW Pharmaceuticals is at Hedf B – 31 – 3 – 12 Dawri Nagar Gate No. 1 Service Road Santacruz East, Mumbai, Maharashtra, India – 400055.
RDW Pharmaceuticals operates in the chemicals industry, in the basic chemicals except fertilizers and nitrogen compounds segment.
RDW Pharmaceuticals can be reached at its registered office: Hedf B – 31 – 3 – 12 Dawri Nagar Gate No. 1 Service Road Santacruz East, Mumbai, Maharashtra, India – 400055.